COMMUNIQUÉ DE PRESSE publié le 28/12/2023 à 14:10, il y a 2 années 1 mois NeoGenomics to Appeal Ruling NeoGenomics, Inc., a leading oncology testing services company, has announced that its subsidiary, NeoGenomics Laboratories, Inc., will appeal the preliminary injunction issued by the United States District Court for the Middle District of North Carolina. The court's ruling stated that Natera, Inc. has demonstrated a likelihood that products using RaDaR technology infringe one of its patents. However, the order allows patients already using RaDaR to continue their use and permits ongoing research projects, studies,
COMMUNIQUÉ DE PRESSE publié le 05/12/2023 à 14:00, il y a 2 années 2 mois NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response NeoGenomics, Inc. to present new data at San Antonio Breast Cancer Symposium highlighting utility of RaDaR for therapy response. The data includes an updated analysis of the TRACER study and the announcement of receipt of the first samples from the SURVIVE clinical trial NeoGenomics RaDaR Assay San Antonio Breast Cancer Symposium TRACER Study SURVIVE Clinical Trial
COMMUNIQUÉ DE PRESSE publié le 14/11/2023 à 13:00, il y a 2 années 3 mois NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
COMMUNIQUÉ DE PRESSE publié le 06/11/2023 à 22:05, il y a 2 années 3 mois NeoGenomics Reports Third Quarter 2023 Results
COMMUNIQUÉ DE PRESSE publié le 24/10/2023 à 13:00, il y a 2 années 3 mois NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
COMMUNIQUÉ DE PRESSE publié le 17/10/2023 à 15:20, il y a 2 années 4 mois NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023
Publié le 18/02/2026 à 18:00, il y a 2 heures 23 minutes Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 janvier 2026
Publié le 18/02/2026 à 18:00, il y a 2 heures 23 minutes Outstanding Shares and Voting Rights Statement at 31 January 2026
Publié le 18/02/2026 à 17:40, il y a 2 heures 43 minutes GROUPE ES - Communiqué sur les résultats 2025
Publié le 18/02/2026 à 13:45, il y a 6 heures 38 minutes NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède
Publié le 18/02/2026 à 19:10, il y a 1 heure 13 minutes Secure Blockchain Announces Definitive Agreement to Acquire Agentic Solutions Limited, Private Placement and Debt Settlement
Publié le 18/02/2026 à 15:15, il y a 5 heures 8 minutes Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now
Publié le 18/02/2026 à 15:00, il y a 5 heures 23 minutes Jaguar Health Announces a Special One-time Stock Dividend
Publié le 18/02/2026 à 14:25, il y a 5 heures 58 minutes Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular
Publié le 18/02/2026 à 14:00, il y a 6 heures 23 minutes Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico
Publié le 18/02/2026 à 19:11, il y a 1 heure 12 minutes flatexDEGIRO adopts new capital allocation policy – increase in annual dividend by a factor of seven planned; 2025 guidance slightly exceeded
Publié le 18/02/2026 à 18:54, il y a 1 heure 29 minutes EQS-Adhoc: flatexDEGIRO SE: Management and Supervisory Board adopt new capital allocation policy; dividend increase to 20% of Net Income targeted; FY 2025 guidance slightly exceeded
Publié le 18/02/2026 à 18:21, il y a 2 heures 1 minute Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 18/02/2026 à 18:00, il y a 2 heures 23 minutes E-PANGO : Décision du Tribunal administratif de Paris en date du 16 février 2026